A look back on the Biden administration’s most significant actions impacting food and farming during the president’s tenure.

The Biden administration's Food and Drug Administration (FDA) released additional details on a proposed rule that would effectively ban cigarettes currently on the market.

President Donald Trump rescinded an executive order issued by former President Joe Biden aimed at finding new models for lowering drug costs. Trump's action didn't affect the caps on seniors' drug costs or Medicare price negotiations that Biden signed into law.

The US Food and Drug Administration is proposing limits on the level of nicotine in cigarettes and some other types of tobacco products in order to make them less addictive, the agency announced Wednesday. “If finalized, the United States would be the ...

In the face of an opioid overdose crisis, President Biden oversaw a historic shift toward harm reduction for addiction.

The proposal in the waning days of the Biden administration leaves it up to President-elect Donald Trump to finalize the effort — or scrap it.

President Joe Biden is using the last days of his presidency to pursue some of the long-term goals of the administration, particularly when it comes to issues of drugs, whether legal or criminalized.

A proposed FDA rule would mandate a reduction to minimally addictive or nonaddictive levels, but the incoming Trump administration isn’t expected to follow through on the idea.

WASHINGTON — President Trump began his second term Monday with a sweeping order aimed at reversing dozens of former President Biden’s top priorities, from regulations aimed at lowering health care costs, to coronavirus outreach, Affordable Care Act expansions, and protections against gender-based discrimination.

It looks like he’s got one last surprise up his sleeve. There’s a new report that says outgoing President Joe Biden is getting ready to make this one shocking move before leaving office. Keep reading below for everything you need to know.

The Trump administration’s first drug pricing action — rescinding a Biden executive order encouraging Medicare to help lower prescription costs — is befuddling drug pricing experts.

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation and patient access to treatments.